Invention Grant
- Patent Title: Benzylideneacetone derivative and use thereof
-
Application No.: US16620847Application Date: 2018-07-27
-
Publication No.: US11629121B2Publication Date: 2023-04-18
- Inventor: Gil Hong Park , Jin Mo Ku , Jung Hun Lee , Da Woon Song , Serk In Park , Han Kyeom Kim , Soon Hyuck Lee , Hong Kyu Kim , Pativada Triveni , Myung Hwan Kim
- Applicant: KORPHARM CO., LTD. , GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR , KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
- Applicant Address: KR Goyang-si; KR Suwon-si; KR Seoul
- Assignee: KORPHARM CO., LTD.,GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR,KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
- Current Assignee: KORPHARM CO., LTD.,GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR,KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
- Current Assignee Address: KR Goyang-si; KR Suwon-si; KR Seoul
- Agency: Bozicevic, Field & Francis LLP
- Agent James S. Keddie
- Priority: KR10-2017-0095699 20170727,KR10-2017-0099768 20170807
- International Application: PCT/KR2018/008531 WO 20180727
- International Announcement: WO2019/022556 WO 20190131
- Main IPC: C07C235/34
- IPC: C07C235/34 ; A23L33/10 ; A23L33/00 ; A61P19/08 ; A61P35/00 ; C07C49/248 ; C07C49/255
Abstract:
The present invention relates to novel benzylideneacetone derivatives or uses thereof, more specifically, the present invention relates to a pharmaceutical composition for preventing or treating, or food composition for ameliorating a cancer or a bone disease comprising a compound defined by Formula 1 or pharmaceutically acceptable salt thereof as an active ingredient.
Public/Granted literature
- US20210139414A1 NOVEL BENZYLIDENEACETONE DERIVATIVE AND USE THEREOF Public/Granted day:2021-05-13
Information query
